Quote | BioCardia Inc. Warrant (NYSE:BCDAW)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $1.00 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 02/12/2020 04:43:25 pm |
News | BioCardia Inc. Warrant (NYSE:BCDAW)
2024-05-14 23:00:19 ET BioCardia, Inc. (BCDA) Q1 2024 Earnings Conference Call May 14, 2024 04:30 PM ET Company Participants Miranda Peto - IR Peter Altman - President and CEO David McClung - CFO Conference Call Participants Lander Egaña-Gorro...
2024-03-27 20:00:12 ET BioCardia, Inc. (BCDA) Q4 2023 Results Conference Call March 27, 2024 04:30 PM ET Company Participants Miranda Peto - Investor Relations Peter Altman - President and Chief Executive Officer David McClung - Chief Financial Officer Pres...
Message Board Posts | BioCardia Inc. Warrant (NYSE:BCDAW)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
BioCardia Inc. Warrant Company Name:
BCDAW Stock Symbol:
NYSE Market:
BioCardia Inc. Warrant Website:
SAN CARLOS, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data ...
SAN CARLOS, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of autologous and allogenic cell therapies, today reported financial results and business highlights for the third quarter of 2020 and filed its quarterly report on Fo...
Paper P ublished in International Journal of Cardiology D emonstrates S afety and T olerability W hile S howing F unctional I mprovement at S ix M onths SAN CARLOS, Calif., Oct. 26, 2020 (GLOBE NEWSWIR...